Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Retrophin Inc (NASDAQ:RTRX)

23.27
Delayed Data
As of 4:00pm ET
 +0.77 / +3.42%
Today’s Change
15.55
Today|||52-Week Range
24.57
+22.93%
Year-to-Date

Today’s Trading

Previous close22.50
Today’s open22.50
Day’s range22.50 - 23.63
Volume396,040
Average volume (3 months)280,920
Market cap$863.7M
Dividend yield--
Data as of 4:00pm ET, 08/16/2017

Growth & Valuation

Earnings growth (last year)-140.69%
Earnings growth (this year)+11.63%
Earnings growth (next 5 years)+137.00%
Revenue growth (last year)+33.74%
P/E ratioNM
Price/Sales5.43
Price/Book2.77

Competitors

 Today’s
change
Today’s
% change
EDITEditas Medicine Inc+0.09+0.44%
FPRXFive Prime Therapeut...+0.75+2.70%
SGMOSangamo Therapeutics...-0.60-5.36%
CRSPCRISPR Therapeutics ...-0.49-2.53%
Data as of 4:00pm ET, 08/16/2017

Financials

Last reporting dateAugust 9, 2017
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$133.6M
Annual profit (last year)-$47.9M
Net profit margin-35.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen J. Aselage
Chief Operating Officer
Neil McFarlane
Corporate headquarters
San Diego, California

Forecasts